LAPTM5–CD40 Crosstalk in Glioblastoma Invasion and Temozolomide Resistance

Background: Glioma therapy is challenged by the diffuse and invasive growth of glioma. Lysosomal protein transmembrane 5 (LAPTM5) was identified as an invasion inhibitor by an in vivo screen for invasion-associated genes. The aim of this study was to decipher the function of LAPTM5 in glioblastoma a...

Descripción completa

Detalles Bibliográficos
Autores principales: Berberich, Anne, Bartels, Frederik, Tang, Zili, Knoll, Maximilian, Pusch, Sonja, Hucke, Nanina, Kessler, Tobias, Dong, Zhen, Wiestler, Benedikt, Winkler, Frank, Platten, Michael, Wick, Wolfgang, Abdollahi, Amir, Lemke, Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289993/
https://www.ncbi.nlm.nih.gov/pubmed/32582531
http://dx.doi.org/10.3389/fonc.2020.00747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289993/
https://www.ncbi.nlm.nih.gov/pubmed/32582531
http://dx.doi.org/10.3389/fonc.2020.00747

Ejemplares similares